154 related articles for article (PubMed ID: 29899942)
1. An effective strategy for recapitulating N-terminal heptad repeat trimers in enveloped virus surface glycoproteins for therapeutic applications.
Lai W; Wang C; Yu F; Lu L; Wang Q; Jiang X; Xu X; Zhang T; Wu S; Zheng X; Zhang Z; Dong F; Jiang S; Liu K
Chem Sci; 2016 Mar; 7(3):2145-2150. PubMed ID: 29899942
[TBL] [Abstract][Full Text] [Related]
2.
Wang C; Lai W; Yu F; Zhang T; Lu L; Jiang X; Zhang Z; Xu X; Bai Y; Jiang S; Liu K
Chem Sci; 2015 Nov; 6(11):6505-6509. PubMed ID: 30090269
[TBL] [Abstract][Full Text] [Related]
3. Stabilizing the native trimer of HIV-1 Env by destabilizing the heterodimeric interface of the gp41 postfusion six-helix bundle.
Kesavardhana S; Varadarajan R
J Virol; 2014 Sep; 88(17):9590-604. PubMed ID: 24920800
[TBL] [Abstract][Full Text] [Related]
4. Site-specific Isopeptide Bridge Tethering of Chimeric gp41 N-terminal Heptad Repeat Helical Trimers for the Treatment of HIV-1 Infection.
Wang C; Li X; Yu F; Lu L; Jiang X; Xu X; Wang H; Lai W; Zhang T; Zhang Z; Ye L; Jiang S; Liu K
Sci Rep; 2016 Aug; 6():32161. PubMed ID: 27562370
[TBL] [Abstract][Full Text] [Related]
5. Antibody elicited against the gp41 N-heptad repeat (NHR) coiled-coil can neutralize HIV-1 with modest potency but non-neutralizing antibodies also bind to NHR mimetics.
Nelson JD; Kinkead H; Brunel FM; Leaman D; Jensen R; Louis JM; Maruyama T; Bewley CA; Bowdish K; Clore GM; Dawson PE; Frederickson S; Mage RG; Richman DD; Burton DR; Zwick MB
Virology; 2008 Jul; 377(1):170-83. PubMed ID: 18499210
[TBL] [Abstract][Full Text] [Related]
6. Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs.
Crespillo S; Cámara-Artigas A; Casares S; Morel B; Cobos ES; Mateo PL; Mouz N; Martin CE; Roger MG; El Habib R; Su B; Moog C; Conejero-Lara F
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18207-12. PubMed ID: 25489108
[TBL] [Abstract][Full Text] [Related]
7. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
Su S; Zhu Y; Ye S; Qi Q; Xia S; Ma Z; Yu F; Wang Q; Zhang R; Jiang S; Lu L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795416
[TBL] [Abstract][Full Text] [Related]
8. The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors.
Zhu Y; Ding X; Yu D; Chong H; He Y
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619552
[TBL] [Abstract][Full Text] [Related]
9. Suitable fusion of N-terminal heptad repeats to achieve covalently stabilized potent N-peptide inhibitors of HIV-1 infection.
Lai W; Wang C; Yan J; Liu H; Zhang W; Lin B; Xi Z
Bioorg Med Chem; 2020 Feb; 28(4):115214. PubMed ID: 31932193
[TBL] [Abstract][Full Text] [Related]
10. The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion.
Sackett K; Shai Y
Biochemistry; 2002 Apr; 41(14):4678-85. PubMed ID: 11926830
[TBL] [Abstract][Full Text] [Related]
11. Probing Vulnerability of the gp41 C-Terminal Heptad Repeat as Target for Miniprotein HIV Inhibitors.
Jurado S; Moog C; Cano-Muñoz M; Schmidt S; Laumond G; Ruocco V; Standoli S; Polo-Megías D; Conejero-Lara F; Morel B
J Mol Biol; 2020 Sep; 432(20):5577-5592. PubMed ID: 32822695
[TBL] [Abstract][Full Text] [Related]
12. Design of a novel peptide inhibitor of HIV fusion that disrupts the internal trimeric coiled-coil of gp41.
Bewley CA; Louis JM; Ghirlando R; Clore GM
J Biol Chem; 2002 Apr; 277(16):14238-45. PubMed ID: 11859089
[TBL] [Abstract][Full Text] [Related]
13. Novel recombinant engineered gp41 N-terminal heptad repeat trimers and their potential as anti-HIV-1 therapeutics or microbicides.
Chen X; Lu L; Qi Z; Lu H; Wang J; Yu X; Chen Y; Jiang S
J Biol Chem; 2010 Aug; 285(33):25506-15. PubMed ID: 20538590
[TBL] [Abstract][Full Text] [Related]
14. ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.
Yu F; Lu L; Liu Q; Yu X; Wang L; He E; Zou P; Du L; Sanders RW; Liu S; Jiang S
Biochim Biophys Acta; 2014 May; 1838(5):1296-305. PubMed ID: 24388952
[TBL] [Abstract][Full Text] [Related]
15. Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat-C-terminal heptad repeat interactions and C-peptides' anti-HIV activity.
Zheng B; Wang K; Lu L; Yu F; Cheng M; Jiang S; Liu K; Cai L
AIDS; 2014 Jun; 28(9):1251-60. PubMed ID: 24625369
[TBL] [Abstract][Full Text] [Related]
16. Extremely Thermostabilizing Core Mutations in Coiled-Coil Mimetic Proteins of HIV-1 gp41 Produce Diverse Effects on Target Binding but Do Not Affect Their Inhibitory Activity.
Cano-Muñoz M; Cesaro S; Morel B; Lucas J; Moog C; Conejero-Lara F
Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33921495
[TBL] [Abstract][Full Text] [Related]
17. Trimeric, coiled-coil extension on peptide fusion inhibitor of HIV-1 influences selection of resistance pathways.
Zhuang M; Wang W; De Feo CJ; Vassell R; Weiss CD
J Biol Chem; 2012 Mar; 287(11):8297-309. PubMed ID: 22235115
[TBL] [Abstract][Full Text] [Related]
18. An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor.
Mische CC; Yuan W; Strack B; Craig S; Farzan M; Sodroski J
Virology; 2005 Jul; 338(1):133-43. PubMed ID: 15950253
[TBL] [Abstract][Full Text] [Related]
19. Conserved residue Lys574 in the cavity of HIV-1 Gp41 coiled-coil domain is critical for six-helix bundle stability and virus entry.
He Y; Liu S; Jing W; Lu H; Cai D; Chin DJ; Debnath AK; Kirchhoff F; Jiang S
J Biol Chem; 2007 Aug; 282(35):25631-9. PubMed ID: 17616522
[TBL] [Abstract][Full Text] [Related]
20. Thermodynamic dissection of the interface between HIV-1 gp41 heptad repeats reveals cooperative interactions and allosteric effects.
Jurado S; Cano-Muñoz M; Polo-Megías D; Conejero-Lara F; Morel B
Arch Biochem Biophys; 2020 Jul; 688():108401. PubMed ID: 32376316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
